Skip to main navigation

Homology Medicines, Inc.

Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • Contact IR

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Governance Highlights

Governance Documents

Title Format
Corporate Governance Guidelines
Corporate Governance Guidelines 242.3 KB
Code of Business Conduct and Ethics
Code of Business Conduct and Ethics 260.5 KB
Code of Business Conduct and Ethics Summary of Changes
Code of Business Conduct and Ethics Summary of Changes 89.7 KB

Committee Charters

Title Format
Nominating and Corporate Governance Committee Charter
Nominating and Corporate Governance Committee Charter 127.4 KB
Audit Committee Charter
Audit Committee Charter 228.8 KB
Compensation Committee Charter
Compensation Committee Charter 118.6 KB
Homology Logo
  • We are Homology
  • Technology Platform
  • Pipeline
  • Patients & Families
  • Clinical Trials
  • Culture & Careers
  • Investors
  • Contact Us

© Copyright 2023 Homology Medicines, Inc. All rights reserved.

  • Terms of Use
  • Accessibility Statement
MENU
  • We are Homology
    • We are Homology
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Technology Platform
    • AAVHSC Platform
    • Gene Therapy
    • Gene Editing
    • GTx-mAb
    • Publications and Presentations
  • Pipeline
  • Patients & Families
    • Community Involvement
    • Patient Stories
    • Expanded Access Policy
  • Clinical Trials
    • Overview
    • Gene Editing Clinical Trial for PKU
    • Gene Therapy Clinical Trial for MPS II
  • Culture & Careers
  • Investors
    • Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Stock Calculator
    • News & Events
      • News Releases
      • Investor Calendar
      • Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor Resources
      • Email Alerts
      • Contact IR